| Literature DB >> 35783136 |
Yin Yang1, Tianpei Wang1,2, Hua Guo1, Ye Sun1,2, Junjun Cao1, Peng Xu3, Yongsong Cai3.
Abstract
Delirium is a common postoperative complication in elderly hip fracture patients that seriously affects patients' lives and health, and early delirium risk prediction, and targeted measures can significantly reduce the incidence of delirium. The purpose of this study was to develop and validate a nomogram for the prediction of postoperative delirium (POD) in elderly hip fracture patients. A total of 328 elderly patients with hip fractures enrolled retrospectively in department 1 of our hospital were randomly divided into the training set (n = 230) and the internal validation set (n = 98). The least absolute shrinkage and selection operator (LASSO) regression analysis was used for feature variable selection, and multivariate logistic regression with a backward stepwise method was used to construct a nomogram in the training set. The discrimination efficacy and calibration efficacy of the nomogram were evaluated through the receiver operating characteristic (ROC) curve and calibration curve, respectively. The clinical usefulness was estimated through decision curve analysis (DCA) and clinical impact curve (CIC) analysis. Another validation set from department 2 of our hospital, containing 76 elderly patients with hip fractures, was used for external validation of the nomogram. A total of 43 (13.1%) and 12 (15.8%) patients had POD in department 1 and department 2, respectively. The nomogram was constructed by three predictors, including dementia, chronic obstructive pulmonary disease (COPD), and albumin level. The nomogram showed good discrimination efficacy and calibration efficacy, with the AUC of 0.791 (95% CI, 0.708-0.873), 0.820 (95% CI, 0.676-0.964), and 0.841 (95% CI, 0.717-0.966) in the training set, the internal validation set, and the external validation set, respectively. Both DCA and CIC demonstrated that this nomogram has good clinical usefulness. The nomogram constructed by dementia, COPD, and albumin level can be conveniently used to predict POD in patients with elderly hip fractures.Entities:
Keywords: albumin; chronic obstructive pulmonary disease; dementia; elderly hip fracture; nomogram; postoperative delirium; prediction model
Year: 2022 PMID: 35783136 PMCID: PMC9243358 DOI: 10.3389/fnagi.2022.914002
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
Patient characteristics of the department 1 and department 2.
| Department 1 ( | Department 2 ( |
| ||
|---|---|---|---|---|
| Delirium (%) | no | 285 (86.9) | 64 (84.2) | 0.669 |
| yes | 43 (13.1) | 12 (15.8) | ||
| Age [mean (SD)] | 81.85 (7.73) | 80.61 (8.70) | 0.218 | |
| BMI [median (IQR)] | 22.00 [19.00, 24.00] | 22.00 [19.00, 24.25] | 0.548 | |
| Sex (%) | male | 95 (29.0) | 23 (30.3) | 0.933 |
| female | 233 (71.0) | 53 (69.7) | ||
| Hypertension (%) | no | 147 (44.8) | 35 (46.1) | 0.946 |
| yes | 181 (55.2) | 41 (53.9) | ||
| CHD (%) | no | 226 (68.9) | 44 (57.9) | 0.089 |
| yes | 102 (31.1) | 32 (42.1) | ||
| Diabetes (%) | no | 251 (76.5) | 55 (72.4) | 0.54 |
| yes | 77 (23.5) | 21 (27.6) | ||
| Cerebral infarction (%) | no | 244 (74.4) | 54 (71.1) | 0.652 |
| yes | 84 (25.6) | 22 (28.9) | ||
| Dementia (%) | no | 305 (93.0) | 63 (82.9) | 0.01 |
| yes | 23 (7.0) | 13 (17.1) | ||
| Pulmonary infection (%) | no | 272 (82.9) | 53 (69.7) | 0.014 |
| yes | 56 (17.1) | 23 (30.3) | ||
| COPD (%) | no | 322 (98.2) | 64 (84.2) | <0.001 |
| yes | 6 (1.8) | 12 (15.8) | ||
| ASA (%) | 0 | 1 (0.3) | 0 (0.0) | 1 |
| ≥1 | 327 (99.7) | 76 (100.0) | ||
| Na+ concentration [median (IQR)] | 139.00 [137.00, 142.00] | 139.00 [137.00, 141.00] | 0.665 | |
| K+ concentration [mean (SD)] | 3.93 (0.48) | 3.97 (0.45) | 0.5 | |
| Ca2+ concentration [mean (SD)] | 2.23 (0.19) | 2.23 (0.15) | 0.976 | |
| ALB [mean (SD)] | 37.80 (5.03) | 36.46 (3.90) | 0.03 | |
| Globulin [median (IQR)] | 25.80 [22.37, 29.50] | 26.60 [24.15, 30.60] | 0.051 | |
| ALT [mean (SD)] | 17.95 (15.90) | 18.57 (21.17) | 0.778 | |
| BUN [median (IQR)] | 7.00 [5.00, 9.00] | 6.00 [5.00, 8.00] | 0.18 | |
| CREA [median (IQR)] | 67.00 [54.00, 84.25] | 65.00 [53.75, 80.25] | 0.253 | |
| Blood glucose [median (IQR)] | 6.59 [5.68, 8.10] | 6.75 [5.86, 8.43] | 0.47 | |
| Erythrocyte count [mean (SD)] | 3.62 (0.66) | 3.52 (0.63) | 0.239 | |
| Hemoglobin [mean (SD)] | 111.13 (19.99) | 109.93 (19.70) | 0.638 | |
| PLT [median (IQR)] | 175.50 [135.75, 224.25] | 188.50 [149.75, 242.00] | 0.155 | |
| Operative duration [mean (SD)] | 104.94 (47.08) | 193.17 (80.02) | <0.001 | |
| Intraoperative blood loss [median (IQR)] | 100.00 [50.00, 200.00] | 100.00 [50.00, 200.00] | 0.5 |
CHD, coronary heart disease; BMI, body mass index; COPD, chronic obstructive pulmonary disease; ALB, albumin; ALT, alanine transaminase; BUN, blood urea nitrogen; CREA, creatinine; PLT, platelet; ASA, American Society of Anesthesiologists Physical Status Classification.
Patient characteristics of the training set.
| Total ( | Non-POD ( | POD ( |
| ||
|---|---|---|---|---|---|
| Age [mean (SD)] | 81.64 (7.65) | 81.42 (7.63) | 83.10 (7.77) | 0.265 | |
| Sex (%) | male | 68 (29.6) | 5 (28.5) | 11 (36.7) | 0.484 |
| female | 162 (70.4) | 143 (71.5) | 19 (63.3) | ||
| BMI [median (IQR)] | 21.00 [19.00, 24.00] | 21.50 [19.00, 24.00] | 21.00 [20.00, 22.75] | 0.643 | |
| Hypertension (%) | no | 98 (42.6) | 88 (44.0) | 10 (33.3) | 0.366 |
| yes | 132 (57.4) | 112 (56.0) | 20 (66.7) | ||
| CHD (%) | no | 157 (68.3) | 137 (68.5) | 20 (66.7) | 1 |
| yes | 73 (31.7) | 63 (31.5) | 10 (33.3) | ||
| Cerebral infarction (%) | no | 167 (72.6) | 145 (72.5) | 22 (73.3) | 1 |
| yes | 63 (27.4) | 55 (27.5) | 8 (26.7) | ||
| Dementia (%) | no | 214 (93.0) | 190 (95.0) | 24 (80.0) | 0.009 |
| yes | 16 (7.0) | 10 (5.0) | 6 (20.0) | ||
| Pulmonary infection (%) | no | 189 (82.2) | 165 (82.5) | 24 (80.0) | 0.798 |
| yes | 41 (17.8) | 35 (17.5) | 6 (20.0) | ||
| COPD (%) | no | 226 (98.3) | 198 (99.0) | 28 (93.3) | 0.084 |
| yes | 4 (1.7) | 2 (1.0) | 2 (6.7) | ||
| ASA (%) | 0 | 1 (0.4) | 1 (0.5) | 0 (0.0) | 1 |
| ≥1 | 229 (99.6) | 199 (99.5) | 30 (100.0) | ||
| Diabetes (%) | no | 178 (77.4) | 155 (77.5) | 23 (76.7) | 1 |
| yes | 52 (22.6) | 45 (22.5) | 7 (23.3) | ||
| Na+ concentration [median (IQR)] | 139.00 [137.00, 141.00] | 139.00 [137.00, 141.00] | 140.50 [137.50, 141.75] | 0.546 | |
| K+ concentration [mean (SD)] | 3.94 (0.49) | 3.94 (0.48) | 3.89 (0.53) | 0.609 | |
| Ca2+ concentration [mean (SD)] | 2.24 (0.19) | 2.23 (0.17) | 2.26 (0.31) | 0.51 | |
| ALB [mean (SD)] | 37.56 (4.69) | 38.13 (4.51) | 33.73 (4.02) | <0.001 | |
| Globulin [median (IQR)] | 25.70 [22.33, 28.60] | 25.80 [22.48, 28.60] | 24.80 [21.65, 29.20] | 0.451 | |
| ALT [mean (SD)] | 17.83 (16.63) | 18.27 (17.65) | 14.90 (6.09) | 0.302 | |
| BUN [median (IQR)] | 7.00 [5.00, 9.00] | 7.00 [5.00, 9.00] | 7.00 [6.00, 9.75] | 0.634 | |
| CREA [median (IQR)] | 69.00 [57.00, 85.00] | 69.00 [57.00, 85.25] | 72.50 [54.00, 82.00] | 0.771 | |
| Blood glucose [median (IQR)] | 6.56 [5.59, 8.21] | 6.51 [5.58, 8.13] | 6.98 [5.72, 8.60] | 0.663 | |
| Erythrocyte count [mean (SD)] | 3.58 (0.61) | 3.57 (0.62) | 3.67 (0.49) | 0.375 | |
| Hemoglobin [mean (SD)] | 111.00 (19.37) | 110.58 (19.98) | 113.73 (14.61) | 0.408 | |
| PLT [median (IQR)] | 172.50 [136.25, 219.50] | 175.00 [136.50, 220.25] | 166.50 [136.75, 214.00] | 0.877 | |
| Operative duration [mean (SD)] | 102.36 (40.49) | 103.38 (41.91) | 95.60 (28.88) | 0.328 | |
| Intraoperative blood loss [median (IQR)] | 100.00 [50.00, 200.00] | 100.00 [50.00, 200.00] | 100.00 [50.00, 137.50] | 0.412 |
CHD, coronary heart disease; BMI, body mass index; COPD, chronic obstructive pulmonary disease; ALB, albumin; ALT, alanine transaminase; BUN, blood urea nitrogen; CREA, creatinine; PLT, platelet; ASA, American Society of Anesthesiologists Physical Status Classification.
Figure 1Selection of feature variables using the least absolute shrinkage and selection operator (LASSO) regression analysis. (A) Cross-validation for the feature variable selection of optimal lambda value in the LASSO model. The left and right dotted vertical lines represent the values of log (lambda.min) and log (lambda.1se). (B) LASSO coefficient profiles of the six feature variables. The dotted vertical line represents the value of log (lambda.min).
Figure 2The nomogram predicts the risk of POD in elderly patients with hip fractures, based on dementia, COPD, and ALB levels. COPD, chronic obstructive pulmonary disease; ALB, albumin.
Results of the multivariable logistic analysis.
| Predictor | Coefficient | SE | OR (95% CI) |
|
|---|---|---|---|---|
| Dementia | 1.453 | 0.632 | 4.275 (1.240–14.742) | 0.021 |
| COPD | 2.097 | 1.054 | 8.14 (1.031–64.241) | 0.047 |
| ALB | −0.229 | 0.054 | 0.795 (0.716–0.884) | 0.00002 |
COPD, chronic obstructive pulmonary disease; ALB, albumin.
Figure 3The results of the ROC curve and calibration analysis of the nomogram in the training set and the internal validation set. (A,B) The AUC and the calibration curve of the nomogram for predicting POD in the training set. (C,D) The AUC and the calibration curve of the nomogram for predicting POD in the internal validation set.
Figure 4The results of the DCA and the CIC analysis of the nomogram in the training set. (A) The DCA curve of the nomogram for predicting POD. It revealed that the nomogramcould obtain a greater net benefit than either the “treat all” or the “treat none” strategy and also get a higher net benefit than each predictor alone. (B) The CIC curve of the nomogram for predicting POD. The solid red line (Number high risk) represents the number of POD patients predicted using the nomogramat each threshold probability; the dotted blue line (number high risk with event) represents the number of true-positive POD patients at each threshold probability.
Figure 5The results of the ROC curve and calibration analysis of the nomogram in the external validation set. (A) The AUC of the nomogram for predicting POD in the external validation set. (B) The calibration curve of the nomogram in the external validation set.